Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Brian Hoyt to Multiple Sclerosis

This is a "connection" page, showing publications Brian Hoyt has written about Multiple Sclerosis.

 
Connection Strength
  
 
 
0.261
  
  1. Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Mult Scler Relat Disord. 2021 Oct; 55:103170.
    View in: PubMed
    Score: 0.135
  2. Domen CH, Greher MR, Hosokawa PW, Barnes SL, Hoyt BD, Wodushek TR. Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis? Arch Clin Neuropsychol. 2020 Jul 24; 35(5):511-516.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)